最近rosetta@home的用户正在检测预测CASP7结构的实验，将在8月4日结束。
CASP7完成设计后，David Baker等人将把用户的计算能力引导到重要的设计问题中，例如开发HIV的疫苗。人类难以对付HIV的主要原因是HIV上的病毒衣壳蛋白（viral coat protein）—gp120，具有许多高度可变环。针对HIV的免疫反应倾向于瞄准这些可变区域，因此相对来说不能起到有效的反应。然而，gp120上具有一些关键的区域是不可变的，因为它们是HIV侵染所必需的。研究小组中的Bill Schief与NIH(National Institutes of Health)D的Peter Kwong等人的研究小组合作，设计了一系列的新型蛋白疫苗来模仿这些HIV的不可变区域。
这些例子仅仅是开始。蛋白设计的潜力就好像生物学自身的多样性一样。具有创造未有的催化剂，改进生物分子的相互作用，和设计新的有用蛋白的能力后，剩下的事就仅受想象力和计算能力所限制了。（以上内容来自华盛顿大学HHMI研究员David Baker）（生物通：亚历）
References
1. P. Bradley et al., "Toward high-resolution de novo structure prediction for small proteins," Science, 309:1868-71, 2005.
2. B. Kuhlman et al., "Design of a novel globular protein fold with atomic level accuracy," Science, 302:1364-8, 2003.
3. D.N. Bolon, S.L. Mayo, "Enzyme-like proteins by computational design," Proc Natl Acad Sci, 98:14274-9, 2001.
4. L.L. Looger et al., "Computational design of receptor and sensor proteins with novel functions," Nature, 423:185-90, 2003.
5. M.A. Dwyer et al, "Computational design of a biologically active enzyme," Science, 304:1967-71, 2004.
6. T. Kortemme et al., "Computational redesign of protein-protein interaction specificity," Nat Struct Mol Biol, 11:371-9, 2004.
7. B.S. Chevalier et al., "Design, activity, and structure of a highly specific artificial endonuclease," Mol Cell, 10:895-905,
2002.
8. J. Ashworth et al., "Computational redesign of endonuclease DNA binding and cleavage specificity," Nature, in press, 2006.
9. R. Nelson, "Structure of the cross-b spine of amyloid-like fibrils," Nature, 435:773-8, 2005.
10. M.J. Thompson et al., "The 3D profile method for identifying fibril-forming segments of proteins," Proc Natl Acad Sci, 103:4074-8, March 14, 2006.
